David A. Siegel Pulmonx Corp Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Pulmonx Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 90,000 shares of LUNG stock, worth $806,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,000
Previous 94,900
5.16%
Holding current value
$806,400
Previous $786,000
22.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LUNG
# of Institutions
130Shares Held
31.4MCall Options Held
500Put Options Held
213K-
Primecap Management CO Pasadena, CA5.51MShares$49.4 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.07MShares$27.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$23.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$20.5 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.53MShares$13.8 Million0.26% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $334M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...